Clinical Trial Update: Vortex - Temporary Percutaneous, Transvalvular Circulatory Support System Feasibility Study [NA]

View source ↗

Summary

A completed feasibility study of the Vortex temporary percutaneous transvalvular circulatory support system for coronary artery disease has posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Vortex temporary percutaneous transvalvular circulatory support system

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Coronary Artery Disease | NA | Status: COMPLETED | Results posted: 2024-04-24